china resources saike pharmacetical co.ltd.
Trade trend analysis
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for china resources saike pharmacetical co.ltd. from 2017 to 2018. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2018, the company has completed 2 transactions, with a transaction quantity of 0.56 and a transaction weight of 0.
- Year Transactions Quantity Weight
- 2017 0 0 0
- 2018 2 0.56 0
Bill of lading data
< 1/2 >- Trade date 2018/09/17 B/L No. ——
- Suppliers china resources saike pharmacetical co.ltd. Buyers axis clinicals ltd.
- POLs —— PODs ahemdabad air acc inamd4
- Supply area China Purchas area India
- Weight —— Amount 812
- Hs code 30049099 Product tags tofacitinib,abs s,eran,commercial v,alu,duct,ce pro
- Product description REFERANCE PRODUCT(R) XELJANZ(TOFACITINIB) 5 MG X 56 TABS SAM PLE FOR NO COMMERCIAL VALUE Expand
- Trade date 2018/09/17 B/L No. ——
- Suppliers china resources saike pharmacetical co.ltd. Buyers axis clinicals ltd.
- POLs —— PODs ahemdabad air acc inamd4
- Supply area China Purchas area India
- Weight —— Amount 560
- Hs code 30049099 Product tags tofacitinib citrate,alu,commercial v,test product,abs s
- Product description TEST PRODUCT(T) TOFACITINIB CITRATE 5 MG X 56 TABS SAMPLE FO R NO COMMERCIAL VALUE Expand
Partners
Total 1- Rank Company Transactions Per Detail
- 1 axis clinicals ltd. indiabuyer,they trade on 2018-09-17 2 100.00% >
Products
Total 9- Products Transactions Per Detail
-
alu
2 100% > -
commercial v
2 100% > -
abs s
2 100% > -
tofacitinib citrate
1 50% > -
test product
1 50% >
+View All
Hscode rank
Total 1- HSCode Name Transactions Per Detail
- HS 30049099 2 100% >